Dr Salahaddin Ubaid is a UK trained consultant interventional Cardiologist working at Cheltenham General and Gloucester Royal hospitals. Additionally, he holds the position of Honorary Clinical Lecturer and Clinical Tutor with the University of Bristol.
Dr Ubaid graduated in 2001. He obtained Membership of the Royal College of Physicians (MRCP) in 2007. He also passed the European Exam in Core Cardiology, formerly known Knowledge based assessment, in 2014. He completed his general and interventional cardiology training in the West Midlands and worked across many large tertiary cardiac centers, including University Hospitals Queen Elizabeth, Birmingham, University Hospitals of North Midlands, University Hospitals Coventry and Warwickshire and New Cross Hospital. Following completion of cardiology training, he undertook 12 months interventional cardiology fellowship at University Hospitals Queen Elizabeth, Birmingham where he further consolidated his skills and experience in complex coronary and structural heart interventions, particularly TAVI.
Dr Ubaid was awarded the Certificate of Excellence in Interventional Cardiology Training from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Paris, France. He is fully accredited by the British Society of Echocardiography in transthoracic and transesophageal echocardiography.
Dr Ubaid was the first cardiologist world-wide to conduct novel research comparing the effectiveness of a new antiplatelet drug in patients presenting with heart attack. In February 2020, he was awarded a Doctor of Medicine (MD) degree from the University of Birmingham for his novel research work. He was the runner up for the Young Investigator Award from the British Cardiovascular Intervention Society (BCIS) in 2017. Dr Ubaid has numerous publications and has presented in cardiology conferences on a national and international level.
He has substantial experience in the management of patients with a wide range of general heart conditions and specialises in the management of coronary heart disease, cardiovascular risk assessment, cardiovascular diseases prevention, and cardiac rehabilitation. In addition, Dr Ubaid has a special interest in sports cardiology, and has completed the necessary training in association with the European Association of Preventive Cardiology, Paris, France.
Dr Ubaid is very keen on medical education. He currently holds the position of Honorary Clinical Lecturer and Clinical Tutor with the University of Bristol. He was awarded a Certificate of “Excellent Cardiology Teaching” from the University of Birmingham, whilst working as a cardiology research and educational fellow.
Dr Salahaddin Ubaid's skills and expertise:
- Coronary Angiography and Coronary Angioplasty (Stenting), a procedure used to widen blocked or narrowed Coronary Arteries
- Transthoracic Echocardiography (Fully accredited from the British Society of Echocardiography)
- Transesophageal Echocardiography (Fully accredited from the British Society of Echocardiography)
- Coronary Physiology Assessment
- Shockwave Intravascular Lithotripsy, is a novel device that modifies calcified lesions via calcium fracture to allow for effective stent deployment
- Rotational Atherectomy, an instrument used to break accumulated calcium in the coronary arteries for effective stent deployment
- Intravascular Ultrasonography (IVUS), provides real time view of the inside of the coronary arteries and allows accurate stents deployment and expansion
- Optical Coherence Tomography (OCT), is an imaging modality that uses near-infrared light to provide high-definition images of the coronary arteries
- Transcatheter Aortic Valve Implantation (TAVI), which involves implanting a new heart aortic valve under local anesthetic to treat aortic valve stenosis
- Intra-aortic Balloon Bump Insertion, which helps support blood pressure whilst undertaking complex coronary stenting procedures and in patients who present with heart attack associated with significant drop in blood pressure, known as cardiogenic shock
- Impella Insertion, a mechanical device that support blood pressure whilst undertaking complex coronary stenting procedures and in patients who present with heart attack associated with significant drop in blood pressure, known as cardiogenic shock
- Arterial Closure/Compression Devices, used to close site of artery puncture following coronary angiography/angioplasty
- Angiographic Assessment of Coronary and Myocardial Blood Flow
- Left Atrial Appendage Occlusion, a procedure undertaken to minimize risk of stroke in patients with atrial fibrillation who cannot tolerate blood thinning medications due to bleeding complications
- Atrial Septal Defects and Patent Foramen Ovale Closure (ASD/PFO)
- Platelet Function Assays
- Ultrasound Guided Puncture of Peripheral Arteries
The symptoms that can be investigated, heart conditions that can be treated and the procedures that can be undertaken by Dr Ubaid are summarised below:
- Chest pain
- Shortness of breath
- Dizzy spells / lightheadedness
- Faints / blackouts / collapse
- Heart murmurs
- High blood pressure related symptoms
- Exercise related symptoms such as palpitations, shortness of breath and dizziness
General and Interventional Cardiology
- Coronary artery disease (stable and unstable angina, heart attack)
- Spontaneous coronary artery dissection (SCAD)
- Heart rhythm problems such as atrial fibrillation and atrial flutter
- Heart valve diseases, mainly aortic valve stenosis, mitral valve prolapse and mitral valve regurgitation
- High blood pressure (Hypertension)
- High Cholesterol including familial hypercholesteraemia
- Heart failure
- Stress induced cardiomyopathy, also known as Broken-heart syndrome or Takotsubo cardiomyopathy
- Hypertrophic cardiomyopathy
- Cancer treatment and your heart
- COVID-19 and your heart
- Diabetes and your heart (diabetes related cardiac conditions)
- Older adults and heart disease
- Pulmonary embolism (clots in the lungs)
- Pericardial diseases such as pericarditis
- Identification of cardiovascular diseases and risk stratification in individuals participating in recreational (for leisure) and competitive (for performance and winning) sports
- Assessment, investigations and management of sport related heart symptoms such as palpitations, shortness of breath and dizziness
- Exercise recommendations (what to do and what not to do) for exercise and sports in healthy individuals
- Exercise recommendation and prescription for patients with:
- Ageing individuals
- Atrial fibrillation
- Heart attack
- Heart valve disease, aortic and mitral valves
- Heart failure
- Heart rhythm abnormalities
- Congenital heart disease
- Myocarditis and pericarditis
- Implantable cardiac devices
- Cancer patients
- Chronic kidney disease
- Return to sport and exercise following cardiovascular events such as heart attack
- Sports pre-participation cardiovascular screening (competitive and recreational sports) for individuals of all ages, aimed at the detection and management of heart conditions associated with sudden cardiac death (SCD). This includes:
- screening adolescent and young athletes, older than 14 years of age
- screening for members of various sporting disciplines
- screening for school students and the general population
- screening athletes with a family history of sudden cardiac death
- Cardiovascular Safety assessment at Sports Arenas
- Training sports organisations staff, schools and other sports institution’s personnel the skills of cardiopulmonary resuscitation (CPR) and the use of Automatic External Defibrillators (AED)
- Wearable technology and your heart (smart watches and fitness trackers)
Cardiovascular Risk Factors; Assessment, Prevention, Management, Secondary Prevention and Cardiac Rehabilitation
- Cardiovascular risk assessment in healthy individuals (assess risk of developing cardiovascular events)
- Cardiovascular risk assessment in patients undertaking non-cardiac operations
- Cardiovascular disease prevention (Heart and vascular diseases such as heart attack and stroke)
- Cardiovascular rehabilitation (physical and psychological recovery following a cardiac event such as a heart attack)
Salahaddin enjoys playing table tennis and football, cycling and walking, travelling and photography.
To book an appointment with Dr Ubaid, please contact Medical Secretary, Amy on 07436689913 or Nuffield Health Outpatient Bookings team on 01242 246574.
Treatments and tests offered by Dr Salahaddin Ubaid at Nuffield Health
- Electrocardiogram (ECG)
- Event monitor
- Cardiac catheterisation (coronary angiogram)
- Zio® XT Cardiac Monitor
- Transthoracic echocardiogram (TTE)
- Cardiac rehabilitation
- Ambulatory blood pressure monitoring (ABPM)
- Coronary Angioplasty (Percutaneous Coronary Intervention or PCI)
- Dressler’s syndrome diagnosed during surgery: lessons to be learned
Salahaddin Ubaid, Polyvios Demetriades , Heyman Luckraz, and Benjamin Wrigley. European Heart Journal - Case Reports (2020) 4, 1–2 IMAGES IN CARDIOLOGY doi:10.1093/ehjcr/ytaa409
An incidental finding of an aortic ductus diverticulum in a patient with acute coronary syndrome
Ayisha Mehtab Khan-Kheil, Salahaddin Ubaid, Gareth Lewis, and Richard P. Steeds. European Heart Journal - Case Reports (2020) 4, 1–2 IMAGES IN CARDIOLOGY doi:10.1093/ehjcr/ytaa315
Intravascular Lithotripsy for Stent Under-Expansion Despite Utilization of Rotational Atherectomy for Plaque Modification.
Cardiovasc Revasc Med 2020 Nov;21(11S):147-148. doi: 10.1016/j.carrev.2019.10.024. Epub 2019 Dec 18.
Cangrelor Versus Ticagrelor in Patients treated with Primary Percuntaneous coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized controlled trial.
Thromb Haemost 2019 Jul;119(7):1171-1181. doi: 10.1055/s-0039-1688789. Epub 2019 May 26.
Cardiovascular Outcomes Following Rotational Atherectomy: A UK Multicentre Experience. Catheterization and cardiovascular interventions
Eftychiou C1, Barmby DS1, Wilson SJ2, Ubaid S3, Markwick AJ3, Makri L1, Blaxill JM1, Spratt JC4, Gunning M3, Greenwood JP5,6. Catheter Cardiovasc Interv. 2016 Oct;88(4):546-553. doi: 10.1002/ccd.26587. Epub 2016 Jun 3.
The effect of Cangrelor versus Ticagrelor on platelet activity, coronary micro-circular function and infarct size in patients suffering acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a randomized controlled trial.
Ubaid, S. Ford, T. Berry, C. Khogali, S. Wrigley, B. Munir, S. Martins, J. Jaumdally, R. Amoah, V. Khan, N. Jon, T. McAlindon, E. [and] Cotton, J. (2018). J Am Coll Cardiol. March 2018, 71(11), Supplement, A1388.
Cangrelor versus Ticagrelor in Primary Percutaneous Coronary Intervention: Platelets, Microcirculation and Infarct Size.
Ubaid, S. Khogali, S. Wrigley, B. Munir, S. Martins, E. McAlindon, Ford, T. Berry, C. Townend, J. and Cotton, J. Heart. January 2018; 104: A8-A9 (Abstract)
Factors associated with long-term cardiovascular events following rotational atherectomy
Christos Eftychiou1; David Barmby1; Simon J. Wilson2; Salahaddin Ubaid3; Andrew J. Markwick3; James C. Spratt4; Mark Gunning3; John Greenwood1 J Am Coll Cardiol. 2014;64(11_S):. doi:10.1016/j.jacc.2014.07.162 TCT 2014
Aging and the Risk of Cardiovascular Diseases
Ubaid S, Heart 2, Geriatric Medicine Journal, April 2016
Cholesterol Lowering in Older Adults
Ubaid S, Cholesterol Lowering in older adults, Heart 2, Geriatric Medicine Journal, April 2015
Evaluation of Syncope in Elderly Patients
Heart 2, Geriatric Medicine Journal, April 2014
Guidance for Junior Doctors on completing Death Certificates
Geriatric Medicine Journal, November 2008.
Extensive Pericardial Thickening without Constriction
Ubaid S. Int J Case Rep Images 2015;6(4):258– 260.
An Unusual Presentation of Primary B-Cell Lymphoma
Ubaid S, Ali I, Whitsey M. Int J Case Rep Images 2015;6(3):178–180.
Atrial Myxoma misdiagnosed as Asthma
ECHO Journal. April 2011 issue
Interventricular septal fibroma.
UK radiology conference, Book of Abstracts, June 2010
Insurers Dr Salahaddin Ubaid works with
Dr Salahaddin Ubaid works with the following private medical insurance providers:
- AXA Health
- AXA - Global Healthcare
- Cigna International
- Vitality Health (Pru Health)
- Aviva Health
- Bupa Global
- The Exeter Friendly
Dr Salahaddin Ubaid does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Salahaddin Ubaid does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Salahaddin Ubaid does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.